Breast cancer (metastatic) - bevacizumab (1st line, with capecitabine): response to consultee, commentator and public comments on the ACD
|
Breast cancer (metastatic) - bevacizumab (1st line, with capecitabine): response to consultee, commentator and public comments on the ACD
04 July 2012 (514.66 Kb 29 sec) |
This page was last updated: 04 July 2012